[go: up one dir, main page]

AR044855A1 - Compuesto de imidazopiridina - Google Patents

Compuesto de imidazopiridina

Info

Publication number
AR044855A1
AR044855A1 ARP040102166A ARP040102166A AR044855A1 AR 044855 A1 AR044855 A1 AR 044855A1 AR P040102166 A ARP040102166 A AR P040102166A AR P040102166 A ARP040102166 A AR P040102166A AR 044855 A1 AR044855 A1 AR 044855A1
Authority
AR
Argentina
Prior art keywords
compound
imidazopiridine
gastric acid
endogenously
exogenously
Prior art date
Application number
ARP040102166A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR044855A1 publication Critical patent/AR044855A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Derivados de imidazopiridinas que inhiben la secreción de ácido gástrico estimulada exógena o endógenamente. Se pueden utilizar en la prevención y tratamiento de enfermedades relacionadas con el ácido gástrico o enfermedades inflamatorias gastrointestinales. Reivindicación 1: Un compuesto de fórmula (1) o una sal farmacéuticamente aceptable de dicho compuesto.
ARP040102166A 2003-06-26 2004-06-22 Compuesto de imidazopiridina AR044855A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0301904A SE0301904D0 (sv) 2003-06-26 2003-06-26 Novel imidazopyridine compound II with therapeutic effect

Publications (1)

Publication Number Publication Date
AR044855A1 true AR044855A1 (es) 2005-10-05

Family

ID=27656637

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040102166A AR044855A1 (es) 2003-06-26 2004-06-22 Compuesto de imidazopiridina

Country Status (28)

Country Link
US (1) US7691875B2 (es)
EP (1) EP1641793B1 (es)
JP (1) JP4701168B2 (es)
KR (1) KR20060030479A (es)
CN (2) CN1809567A (es)
AR (1) AR044855A1 (es)
AT (1) ATE386033T1 (es)
AU (1) AU2004249655B2 (es)
BR (1) BRPI0411728A (es)
CA (1) CA2530181A1 (es)
DE (1) DE602004011773T2 (es)
DK (1) DK1641793T3 (es)
ES (1) ES2300796T3 (es)
HR (1) HRP20080179T3 (es)
IL (1) IL172530A0 (es)
IS (1) IS8258A (es)
MX (1) MXPA05013643A (es)
MY (1) MY140718A (es)
NO (1) NO20060425L (es)
PL (1) PL1641793T3 (es)
PT (1) PT1641793E (es)
RU (1) RU2348634C2 (es)
SE (1) SE0301904D0 (es)
TW (1) TW200503702A (es)
UA (1) UA81953C2 (es)
UY (1) UY28384A1 (es)
WO (1) WO2004113339A1 (es)
ZA (1) ZA200510455B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0719481A2 (pt) * 2006-12-19 2014-02-11 Genentech Inc " composto, método de indução de apoptose em uma célula, de sensibilização de uma célula, para inibir a ligação de uma proteína iap a uma proteína caspase, para tratar uma doença ou condição associada com a superexpressão de uma proteína iap e para tratar câncer"
CN106279151A (zh) * 2015-06-26 2017-01-04 江苏太瑞生诺生物医药科技有限公司 5-(2-(8-((2,6-二甲基苄基)氨基)-2,3-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺基)乙氧基)-5-氧代戊酸的固体形式及其制备方法
KR101777971B1 (ko) 2016-07-05 2017-09-12 제일약품주식회사 이미다조[1,2-a]피리딘 유도체, 이의 제조방법 및 이의 용도

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
SE9700661D0 (sv) * 1997-02-25 1997-02-25 Astra Ab New compounds
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE9802794D0 (sv) 1998-08-21 1998-08-21 Astra Ab New compounds
PT1368006E (pt) 2001-02-13 2006-08-31 Astrazeneca Ab Nova formulacao de libertacao modificada
SE0102808D0 (sv) 2001-08-22 2001-08-22 Astrazeneca Ab New compounds

Also Published As

Publication number Publication date
MXPA05013643A (es) 2006-02-24
CN101941968A (zh) 2011-01-12
US7691875B2 (en) 2010-04-06
RU2348634C2 (ru) 2009-03-10
EP1641793B1 (en) 2008-02-13
UA81953C2 (uk) 2008-02-25
BRPI0411728A (pt) 2006-08-08
EP1641793A1 (en) 2006-04-05
IS8258A (is) 2006-01-23
NO20060425L (no) 2006-03-24
JP4701168B2 (ja) 2011-06-15
HRP20080179T3 (hr) 2008-05-31
SE0301904D0 (sv) 2003-06-26
TW200503702A (en) 2005-02-01
JP2007521266A (ja) 2007-08-02
CA2530181A1 (en) 2004-12-29
HK1088315A1 (en) 2006-11-03
US20070066642A1 (en) 2007-03-22
PT1641793E (pt) 2008-04-17
IL172530A0 (en) 2006-04-10
UY28384A1 (es) 2005-01-31
DE602004011773D1 (de) 2008-03-27
AU2004249655A1 (en) 2004-12-29
ATE386033T1 (de) 2008-03-15
ZA200510455B (en) 2007-01-31
DK1641793T3 (da) 2008-05-26
WO2004113339A1 (en) 2004-12-29
MY140718A (en) 2010-01-15
DE602004011773T2 (de) 2009-02-05
KR20060030479A (ko) 2006-04-10
RU2005141059A (ru) 2006-08-10
CN1809567A (zh) 2006-07-26
ES2300796T3 (es) 2008-06-16
AU2004249655B2 (en) 2008-04-17
PL1641793T3 (pl) 2008-07-31

Similar Documents

Publication Publication Date Title
SE9801526D0 (sv) New compounds
ES2178169T3 (es) Compuestos para la inhibicion de la secrecion de acido gastrico.
TR200200160T2 (tr) Antiinflamatuar ajanlar olarak imidazoller ve triazoller
CR6682A (es) Inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorios, autoinmunes y respiratorias
SE9802794D0 (sv) New compounds
WO2007044085A3 (en) Heteroaryl compounds and their uses as therapeutic agents
CY1114038T1 (el) Παραγωγα ιμιδαζοπυριδινης τα οποια αναστελλουν την εκκριση γαστρικου οξεος
SE0102808D0 (sv) New compounds
SE9802793D0 (sv) New compounds
DE60121345D1 (de) Alkylierte imidazopyridinderivate
SE9401197D0 (sv) Active compounds
BR0305708A (pt) Derivados de benzimidazol para o tratamento de disfunção sexual
MY119012A (en) New compounds
NO20064732L (no) Alfa-aminoamidderivater nyttige i behandlingen av urolige bein-syndromet og additive lidelser
NO20052858L (no) Nye tricykliske forbindelser som LTD4-antagonister
AR044853A1 (es) Compuesto de imidazopiridina
AR044855A1 (es) Compuesto de imidazopiridina
NO20070250L (no) S-Tenatoprazol-natriummonohydratsalt og dennes anvendelse i form av en protonpumpe-inhibitor
AR044854A1 (es) Compuesto de imidazopiridina
SE0301903D0 (sv) Novel imidazopyridine compound III with therapeutic effect
AR045724A1 (es) Composicion farmaceutica orodispersable de un compuesto antitrombotico
NO20065200L (no) Dialkoksy-imidazopyridinderivater
US6541495B1 (en) Carboxylic acid derivatives as inhibitors of hyperproliferation diseases
NO20070058L (no) Amino-halogen-imidazopyridiner som protonpumpeinhibitorer
ECSP045295A (es) Composiciones farmacéuticas que comprenden 2-(4-etoxi-fenil)-3-(4-metanosulfonil-fenil)-pirazolo'1,5-bipiridacina en forma nanoparticulada

Legal Events

Date Code Title Description
FB Suspension of granting procedure